Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm

Chest

Volumn 131, Issue 2, 2007, Pages 489-496

  Kyriacou, Demetrios N ^a   Yarnold, Paul R ^a   Stein, Adam C ^a   Schmitt, Brian P ^b   Soltysik, Robert C ^c   Nelson, Regina R ^a   Frerichs, Ralph R ^d   Noskin, Gary A ^a   Belknap, Steven M ^a   Bennett, Charles L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Algorithm; Anthrax; Bioterrorist attack

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHM; ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RADIODIAGNOSIS; TERRORISM; THORAX RADIOGRAPHY;

EID: 33847167734     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1687     Document Type: Article

References (65)

1. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002. JAMA 2002; 287:2236-2252
2. Brachman PS. Bioterrorism: an update with a focus on anthrax. Am J Epidemiol 2002; 155:981-987
3. Swartz MH. Recognition and management of anthrax: an update. N Engl J Med 2001; 345:1621-1626
4. Enserink M. Biodefense hampered by inadequate tests. Science 2001; 294:1266-1267
5. Shafazand S, Doyle R, Ruoss S, et al. Inhalational anthrax: epidemiology, diagnosis, and management. Chest 1999; 116:1369-1376
6. Eitzen EM. Framing the issues. In: Knobler SL, Mahmoud AAF, Pray LA, eds. Biological threats and terrorism: assessing the science and response capabilities. Washington, DC: National Academy Press, Institute of Medicine, 2002; 32-34
7. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA 2002; 287:898-900
8. Bravata DM, Sundaram V, McDonald KM, et al. Evaluating detection and diagnostic decision support systems for bioterrorism response. Emerg Infect Dis 2004; 10:100-108
9. Buehler JW, Hopkins RS, Overhage JM, et al. Framework for evaluating public health surveillance systems for early detection of outbreaks. MMWR Morb Mortal Wkly Rep 2004; 53:1-11
10. Buehler JW, Berkelman RL, Hartley DM, et al. Syndromic surveillance and bioterrorism-related epidemics. Emerg Infect Dis 2003; 9:1197-1204
11. Rotz LD, Hughes JM. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease. Nat Med 2004; 10:s130-s136
12. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001; 50:941-948
13. Centers for Disease Control and Prevention. Notice to readers: considerations for distinguishing influenza-like illness from inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001; 50:984-986
14. Mayer TA, Morrison A, Bersoff-Matcha S, et al. Inhalational anthrax due to bioterrorism: would current centers for the Disease Control and Prevention have identified the 11 patients with inhalational anthrax from October through November 2001? Clin Infect Dis 2003; 36:1275-1283
15. Kuehnert MJ, Doyle TJ, Hill HA, et al. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clin Infect Dis 2003; 36:328-336
16. Hupert N, Bearman GML, Mushlin AI, et al. Accuracy of screening for inhalational anthrax after a bioterrorist attack. Ann Intern Med 2003; 139:337-345
17. Howell JM, Mayer TA, Handflin D, et al. Screening for inhalational anthrax due to bioterrorism: evaluating proposed screening protocols. Clin Infect Dis 2004; 39:1842-1847
18. Kyriacou DN, Stein AC, Yarnold PR, et al. Clinical predictors of bioterrorism-related inhalational anthrax. Lancet 2004; 364:449-452
19. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey. 2002 emergency department summary. Adv Data 2004; 340:1-34
20. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001; 7:933-944
21. Barakat LA, Quentzel HL, Jernigan JA, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002; 287:863-868
22. Yarnold PR, Soltysik RC, McCormick C, et al. Application of multivariable optimal discriminant analysis in general internal medicine. J Gen Intern Med 1995; 10:601-606
23. Yarnold PR, Soltysik RC. Optimal data analysis: guidebook with software for Windows. Washington, DC: APA Books, 2004
24. Gold H. Anthrax: a report of one hundred seventeen cases. Arch Intern Med 1955; 96:387-396
25. Brachman PS. Inhalation anthrax. Ann N Y Acad Sci 1980; 353:83-93
26. Plotkin SA, Brachman PS, Utell M, et al. An epidemic of inhalation anthrax, the first in the twentieth century: I. Clinical features. Am J Med 1960; 29:992-1001
27. Brachman PS, Plotkin SA, Bumford FH, et al. An epidemic of inhalation anthrax: the first in the twentieth century: II. Epidemiology. Am J Hyg 1960; 72:6-23
28. LaForce FM, Bumford FH, Feeley JC, et al. Epidemiologic study of a fatal case of inhalation anthrax. Arch Environ Health 1969; 18:798-805
29. Vessal K, Yeganehdoust J, Dutz W, et al. Radiological changes in inhalation anthrax: a report of radiological and pathological correlation in two cases. Clin Radiol 1975; 26:471-475
30. Severn M. A fatal case of pulmonary anthrax. BMJ 1976; 1:748
31. Suffin SC, Carnes WH, Kaufmann AF. Inhalation anthrax in a home craftsman. Hum Pathol 1978; 9:594-597
32. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8:1019-1028
33. Bush LM, Abrams BH, Beall A, et al. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001; 345:1607-1610
34. Traeger MS, Wiersma ST, Rosenstein NE, et al. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis 2002; 8:1029-1034
35. Mayer TA, Bersoff-Match S, Murphy C, et al. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA 2001; 286:2549-2553
36. Dewan PK, Fry AM, Laserson K, et al. Inhalational anthrax outbreak among postal workers, Washington DC, 2001. Emerg Infect Dis 2002; 8:1066-1072
37. Borio L, Frank D, Mani V, et al. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA 2002; 286:2554-2559
38. Greene CM, Reefhuis J, Tan C, et al. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis 2002; 8:1048-1055
39. Mina B, Dym JP, Kuepper F, et al. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. JAMA 2002; 287:858-862
40. Krol CM, Uszynski M, Dillon EH, et al. Dynamic CT features of inhalational anthrax infection. AJR Am J Roentgenol 2002; 178:1063-1066
41. Gill JR, Melinek J. Inhalational anthrax: gross autopsy Findings. Arch Pathol Lab Med 2002; 126:993-994
42. Griffith KS, Mead P, Armstrong GL, et al. Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis 2003; 9:681-688
43. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalational anthrax; Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001; 50:1049-1051
44. Margolis CZ. Uses of clinical algorithms. JAMA 1983; 249:627-632
45. Feinstein AR. An analysis of diagnostic reasoning: III. The construction of clinical algorithms. Yale J Biol Med 1974; 47:5-32
46. Sox HC, Blatt MA, Higgins MC, et al. Medical decision making. Boston, MA: Butterworth-Heinemann, 1988
47. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. New York, NY: Lippincott Williams & Wilkins, 1991
48. Fonarow GC, Adams KF, Yancy CW, et al. Risk stratification for in-hospital mortality in acute decompensated heart failure: classification and regression tree analysis. JAMA 2005; 293:572-580
49. Yarnold PR, Soltysik RC, Bennett CL. Predicting in-hospital mortality of patients with AIDS-related Pneumocystis carinii pneumonia: an example of hierarchically optimal classification tree analysis. Stat Med 1997; 16:1451-1463
50. Yarnold PR, Soltysik RC, Martin GJ. Heart rate variability and susceptibility for sudden cardiac death: an example of multivariable optimal discriminant analysis. Stat Med 1994; 30:1015-1021
51. Yarnold PR, Soltysik RC, Lefevre F, et al. Predicting in-hospital mortality of patients receiving cardiopulmonary resuscitation: unit-weighted MultiODA for binary data. Stat Med 1998; 17:2405-2414
52. Lyles RH, Allen AS. Estimating crude or common odds ratios in case-control studies with informatively missing exposure data. Am J Epidemiol 2002; 155:274-281
53. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 1995; 142:1255-1264
54. Holty JE, Bravata DM, Hau L, et al. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med 2006; 144:270-280
55. Halm EA, Teirstein AS. Management of community-acquired pneumonia. N Engl J Med 2002; 347:2039-2045
56. Metley JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003; 138:109-118
57. Basi SK, Marrie TJ, Huang JQ, et al. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 2004; 117:305-311
58. Albaum MN, Hill LC, Murphy M, et al. Interobserver reliability of the chest radiograph in community-acquired pneumonia. Chest 1996; 110:343-350
59. Hopstaken RM, Witbraad T, van Engelshoven JMA, et al. Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections. Clin Radiol 2004; 59:743-752
60. Fine MJ, Stone RA, Singer DE, et al. Process and outcomes of care for patients with community-acquired pneumonia. Arch Intern Med 1999; 159:970-980
61. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997; 46:1-55
62. Bravata DM, McDonald KM, Smith WM, et al. Systematic review: surveillance systems for the early detection of bioterrorism-related diseases. Ann Intern Med 2004; 140:910-922
63. Quinn CP, Semenova VA, Elie CM, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002; 8:1103-1110
64. Fasanella A, Losito S, Adone R, et al. PCR assay to detect Bacillus anthracis spores in heat-treated specimens. J Clin Microbiol 2003; 41:896-899
65. Stephenson J. Rapid anthrax test approved. JAMA 2004; 292:30